Building laboratory infrastructure to support scale-up of HIV/AIDS treatment, care, and prevention: In-country experience

American Journal of Clinical Pathology

Volumn 131, Issue 6, 2009, Pages 875-886

  Abimiku, Alash'le G ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF HUMAN VIROLOGY NIGERIA   (Nigeria)

Author keywords

AIDS; Care; HIV; Laboratory; Prevention; Treatment

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CONFERENCE PAPER; HEALTH CARE FACILITY; HEALTH CARE FINANCING; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL INSTRUMENTATION; NIGERIA; PATIENT CARE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCALE UP; STAFF TRAINING; TUBERCULOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; COMMUNITY HEALTH SERVICES; DEVELOPING COUNTRIES; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; LABORATORIES; NIGERIA;

EID: 67149101030     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPELMG6GX6RQSM     Document Type: Conference Paper

References (3)

1. Kamwi R, Kenyon T, Newton G. PEPFAR and HIV prevention in Africa. Lancet. 2006;367:1978-1979. (Pubitemid 43867691)
2. Abimiku AG, Stern TL, Zwandor A, et al. Subgroup G HIV type 1 isolates from Nigeria. AIDS Res Hum Retroviruses. 1994;10:1581-1583. (Pubitemid 24382213)
3. Dada AJ, Oyewole F, Onofowokan R, et al. Demographic characteristics of retroviral infections (HIV-1, HIV-2, and HTLV-I) among female professional sex workers in Lagos, Nigeria. J Acquir Immune Defic Syndr. 1993;6:1358-1363. (Pubitemid 2016535)